The Royal Hallamshire Hospital is a general and teaching hospital located in Sheffield, South Yorkshire, England. It is in the city's West End, facing Glossop Road and close to the main campus of University of Sheffield and the Collegiate Crescent campus of Sheffield Hallam University.

There are 850 beds in Royal Hallamshire Hospital.

During the past decade, Royal Hallamshire Hospital conducted 85 clinical trials. In the 10-year time frame, 85 clinical trials started and 49 clinical trials were completed, i.e. on average, 57.6% percent of trials that started reached the finish line to date. In the past 5 years, 18 clinical trials started and 26 clinical trials were completed. i.e. 144.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Hallamshire Hospital" #1 sponsor was "Sheffield Teaching Hospitals NHS Foundation Trust" with 18 trials, followed by "University College, London" with 10 trials sponsored, "Hoffmann-La Roche" with 6 trials sponsored, "Pfizer" with 5 trials sponsored and "Biogen" with 5 trials sponsored. Other sponsors include 104 different institutions and companies that sponsored additional 90 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Hallamshire Hospital" #1 collaborator was "Cancer Research UK" with 8 trials as a collaborator, "Sheffield Teaching Hospitals NHS Foundation Trust" with 6 trials as a collaborator, "National Institute for Health Research, United Kingdom" with 4 trials as a collaborator, "Queen Mary University of London" with 3 trials as a collaborator and "The Leeds Teaching Hospitals NHS Trust" with 3 trials as a collaborator. Other collaborators include 118 different institutions and companies that were collaborators in the rest 112 trials.

According to Clinical.Site data, the most researched conditions in "Royal Hallamshire Hospital" are "Lymphoma" (7 trials), "Prostate Cancer" (7 trials), "Multiple Sclerosis" (6 trials), "Pulmonary Arterial Hypertension" (6 trials) and "Multiple Myeloma" (5 trials). Many other conditions were trialed in "Royal Hallamshire Hospital" in a lesser frequency.

Most popular intervention types in "Royal Hallamshire Hospital" are "Drug" (96 trials), "Other" (24 trials), "Device" (21 trials), "Biological" (17 trials) and "Procedure" (12 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (31 trials), "Cyclophosphamide" (4 trials), "Dexamethasone" (4 trials), "placebo" (4 trials) and "Fludarabine" (3 trials). Other intervention names were less common.

The vast majority of trials in "Royal Hallamshire Hospital" are 127 trials for "All" genders, 16 trials for "Male" genders and 9 trials for "Female" genders.

Currently, there are NaN active trials in "Royal Hallamshire Hospital". undefined are not yet recruiting, 15 are recruiting, 12 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 90 completed trials in Royal Hallamshire Hospital, undefined suspended trials, and 17 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Hallamshire Hospital, 6 "Phase 1" clinical trials were conducted, 36 "Phase 2" clinical trials and 69 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 7 trials, and there were also 27 trials that are defined as “Not Applicable".